The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- PEACE Magazine @22 celebrates 20+2 brilliant female muslim graduates
- Nigeria consuming most of world’s polio vaccines without much result – Official
- Nasarawa: 196 persons arrested for violating sanitation law
- Kaduna launches ‘Project 10 Million’ to combat hypertension, diabetes
- G20 affirms commitment to transition from fossil fuels
- Vitamin E supplements, Selenium increase prostate cancer risk
- Flooding: FG begins assessment of dams
- NYSC launches tree planting campaign in Sokoto
